Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
T MatsuyamaP P Foa

Abstract

Pancreatic glucagon (PG) and other glucagon-like immunoreactive materials (GLI) were measured in the plasma of normal and of newly diagnosed untreated diabetic children, using an antiglucagon serum (AGS) highly specific for pancreatic glucagon (AGS 18) and an AGS which crossreacts with extracts of intestinal mucosa (AGS 10). Gut GLI was considered to be the difference between "total" GLI (AGS 10) and PG (AGS 18). Glucose and immunoreactive insulin (IRI) were also measured. PG, total GLI and gut GLI were significantly elevated in children with severe insulin insufficiency and were reduced to normal by insulin treatment, even though a significant fasting hyperglycemia was still present. In three diabetic children who had high initial plasma IRI levels the three glucagon fractions were normal. We conclude that insulin insufficiency is characterized not only by high plasma levels of PG as previously reported, but also of gut GLI. These abnormalities can be corrected by the administration of insulin.

Citations

Oct 12, 2013·Clinical Medicine : Journal of the Royal College of Physicians of London·Viktor Rosival
Oct 5, 2014·The Journal of Emergency Medicine·Viktor Rosival
Jul 7, 2012·Current Diabetes Reports·Claire M Issa, Sami T Azar
Mar 30, 2016·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Viktor Rosival
Apr 1, 1978·The Journal of Pediatrics·A L Rosenbloom
Dec 22, 1999·Endocrine Reviews·T J Kieffer, J F Habener
Jan 1, 1987·Endocrine Research·P L Brubaker, M Vranic
Mar 31, 2016·Pediatric Emergency Care·Viktor Rosival
Jun 11, 1988·The American Journal of Physiology·D J PillionW E Grizzle
Nov 14, 1997·The American Journal of Physiology·K D FischerP L Brubaker
Jul 1, 1977·Clinics in Endocrinology and Metabolism·S Pek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.